Novavax is Under Attack

Novavax is Under Attack

Novavax tried to fulfill more than 2 billion doses of vaccine, but the campaign is now delaying too much due to production lags. Is that a sell sign for investors?

The plans were too big

Novavax (NVAX), the world’s vaccine distributor has been counting on U.S. companies to provide more than 2 billion doses to lower and middle-income countries by the end of 2022. In case of success, the company would have a crucial role in the fight with Covid-19.

But the campaign has already been delayed significantly because of production lags and is now likely to fall short by more than 1 billion doses as a key supplier faces significant hurdles in proving it can manufacture a shot that meets regulators’ quality standards.

The U.S. government invested $1.6 billion in Novavax in 2020 — the most it devoted to any vaccine maker at the time — in hopes that it would offer the world another option for a safe and effective vaccine to help protect against Covid-19. But the company has consistently run into production problems. The methods it used to test the purity of the vaccine have fallen short of regulators’ standards and the company has not been able to prove that it can produce high-quality vaccine shots.

Another big problem is that purity levels that have been set by FDA are not met by Novavax. The company only has around 70% purity in every batch of the vaccines, with requirements are at 90%.

What about the stock?

Falling by more than 50% since September 24, the price chart of the NVAX is still looking bearish. Considering given problems with vaccines production and distribution, we suppose the company to plunge even more. This means the support levels now are not the pivotal points: the price can react to them but will probably continue its downtrend. Don’t forget to take your profit on these levels.  

Novavax daily chart

Support: 120.0; 103.0; 78.0

Resistance: 160.0; 190.0; 260.0

Author: FBS Analyst Team

Lainnya dari penulis ini

Menyerupai

01.07.2022 16:24 Kapan Pasar Saham AS yang Turun akan Berakhir?

Saham AS memberikan paruh tahun pertama terburuk dalam lebih dari 50 tahun, yang dipicu oleh upaya The Fed untuk mengendalikan inflasi dan meningkatnya kekhawatiran tentang resesi.

01.04.2022 20:14 Saham Terbaik untuk Dibeli di Bulan April! 

Bulah April telah tiba, investor mencari peluang bagus di pasar saham. Ada dua industri yang terlihat menjanjikan untuk masa mendatang; saham kendaraan listrik (EV) dan saham perbankan.

16.02.2022 17:43 Walmart akan Mengumumkan Laporan Pendapatan pada 17 Februari

Apa yang akan terjadi? Walmart, perusahaan ritel multinasional Amerika, akan mengumumkan laporan pendapatannya untuk kuartal keempat pada 17 Februari sebelum pasar saham dibuka (16.30 GMT+2).

Berita terbaru

02.04.2024 07:03 Yen Terus Terpuruk Mendekati Level Terendah Multi-Dekade

Yen Jepang gagal memikat para investor pada perdagangan Selasa (02/04/2024) meski ada peluang atas kemungkinan intervensi dan..Sentimen penghindaran risiko masih berpotensi memberikan kekuatan pada safe-haven

01.04.2024 08:22 Sanggupkan Emas Berlama-lama di Puncak?

XAUUSD naik ke rekor tertinggi baru pada perdagangan Senin (01/04/2024), di tengah meningkatnya spekulasi penurunan suku bunga..melanjutkan kenaikan kuat minggu lalu hingga membentuk level puncak baru sepanjang masa

01.04.2024 07:11 Sebagian Pasar Masih Libur, Yen Stabil di Bawah 152

Pasar saham Asia sebagian masih libur dan sebagian lagi menguat pada perdagangan Senin (01/04/2024), karena optimisme data pabrikan Tiongkok mendukung..potensi intervensi otoritas Jepang terhadap yen Jepang diperkirakan berada di zona 152 – 155 yen.